Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Proton Radiotherapy and Gemcitabine for Resected Pancreatic Cancer
NCT01553019Phase 2Completed
- Sponsor
- University of Florida
- Start
- Oct 2011
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in pancreatic adenocarcinoma (PDAC), sponsored by University of Florida. Started Oct 2011; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01553019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553019.